Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction

Creative Commons License

ENHOŞ A., KARAÇÖP E.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, vol.17, pp.441-452, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17
  • Publication Date: 2021
  • Doi Number: 10.2147/tcrm.s307768
  • Journal Name: THERAPEUTICS AND CLINICAL RISK MANAGEMENT
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals
  • Page Numbers: pp.441-452
  • Keywords: acute myocardial infarction, aspirin, infarct size, primary prevention, PERCUTANEOUS CORONARY INTERVENTION, CARDIAC MAGNETIC-RESONANCE, LEFT-VENTRICULAR FUNCTION, PRIMARY PREVENTION, ADVERSE OUTCOMES, ELEVATION, TROPONIN, DISEASE, MORTALITY
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Background: The study aimed to evaluate the impact of antecedent aspirin use on infarct size, bleeding and composite endpoint in patients with de novo acute myocardial infarction.